Panagora Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.22M | Sell |
148,790
-1,118
| -0.7% | -$61.8K | 0.04% | 282 |
|
|
2025
Q1 | $7.25M | Buy |
+149,908
| New | +$7.25M | 0.04% | 294 |
|
|
2022
Q1 | – | Sell |
-7,225
| Closed | -$247K | – | 1577 |
|
|
2021
Q4 | $247K | Sell |
7,225
-24,212
| -77% | -$828K | ﹤0.01% | 1425 |
|
|
2021
Q3 | $557K | Sell |
31,437
-105,761
| -77% | -$1.87M | ﹤0.01% | 1271 |
|
|
2021
Q2 | $6.16M | Sell |
137,198
-92,315
| -40% | -$4.14M | 0.03% | 394 |
|
|
2021
Q1 | $5.94M | Sell |
229,513
-7,169
| -3% | -$186K | 0.03% | 423 |
|
|
2020
Q4 | $4.77M | Buy |
236,682
+77,828
| +49% | +$1.57M | 0.03% | 443 |
|
|
2020
Q3 | $3.11M | Buy |
158,854
+8,160
| +5% | +$160K | 0.02% | 506 |
|
|
2020
Q2 | $2.66M | Buy |
150,694
+105,195
| +231% | +$1.86M | 0.02% | 572 |
|
|
2020
Q1 | $321K | Buy |
+45,499
| New | +$321K | ﹤0.01% | 1296 |
|
|
2018
Q4 | – | Sell |
-3,107
| Closed | -$32K | – | 2509 |
|
|
2018
Q3 | $32K | Sell |
3,107
-2,666
| -46% | -$27.5K | ﹤0.01% | 2127 |
|
|
2018
Q2 | $39K | Hold |
5,773
| – | – | ﹤0.01% | 2087 |
|
|
2018
Q1 | $50K | Buy |
+5,773
| New | +$50K | ﹤0.01% | 2033 |
|